Skip to content

Committees:

Attributes and Skills Provided to the Board:

Expertise Provided to the Board:

Michael Rosenblatt, MD currently services as Senior Partner of Flagship Pioneering, a major life sciences venture-capital firm that originates new biotech companies. Dr. Rosenblatt has deep leadership and executive experience in the biotechnology industry, including serving as Chief Medical Officer of Merck (NYSE: MRK) and having contributed to Moderna’s coronavirus vaccine efforts. He also has deep board-level and management team experience as a founding scientist, scientific advisory Board member and director of more than a dozen biopharmaceutical companies. Dr. Rosenblatt has significant academic leadership experience as a dean and professor at prestigious medical schools. He is also a renowned leader in the biotech space, including as a winner of the Fuller Albright Award, with extensive expertise in drug discovery and medical research. He brings unique industry insights to the Azenta Board, particularly as it relates to the customer perspective, research and development, as well as opportunities in the marketplace.